So, it would appear little old Betaville's RARE alert from last week about Gurnet Point Capital's interest in purchasing US-listed Paratek Pharmaceuticals was spot on.
In case you don't recall, Betaville published a RARE Alert in March about the takeover rumours circulating around Paratek Pharmaceuticals. Below is the link:..
Gurnet Point Capital is said to be one of the private equity firms that has been circling Paratek Pharmaceuticals, the US-listed biopharmaceutical company.
Earlier this year Betaville Intelligence reported that Paratek Pharmaceuticals may have attracted takeover interest from a private equity suitor.
People following the situation said Gurnet Point Capital has been studying the purchase of Paratek Pharmaceuticals...
Paratek Pharmaceuticals, the US-listed biopharmaceutical company, is at the centre of takeover speculation.
People following following the situation have heard rumours Paratek has attracted takeover interest.
Some people following the situation suggested the suitor circling Paratek is a private equity firm.
To be clear, the above story is RARE.
In case you don't remember the definition of RARE I have pasted it below:..